Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. (TARO) on the NYSE Exchange
Company overview
Taro Pharmaceutical Industries Ltd. is a publicly listed company from USA with shares traded on NYSE under the ticker TARO. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for TARO are bid 42.96 USD and ask 42.98 USD.
Use the chart to review recent momentum, identify key price areas, and track how Taro Pharmaceutical Industries Ltd. is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add TARO to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.
Key facts
- Exchange: NYSE
- Company: Taro Pharmaceutical Industries Ltd.
- Ticker: TARO
- Country: USA
- Bid: 42.96 USD
- Ask: 42.98 USD
- Quotes: real-time, auto-updated
Risk
Risk Warning: Past performance of TARO does not predict future returns.
FAQ
Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Taro Pharmaceutical Industries Ltd. (TARO) in R StocksTrader. Create and verify your profile, fund the account, search for TARO, and choose the instrument type available to you. Add TARO to your Watchlist to track moves and manage open positions throughout 2025.
TARO trades on NYSE and is issued by Taro Pharmaceutical Industries Ltd.. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for TARO match your plan.
Quotes update automatically in real time. Current levels for TARO are bid 42.96 USD and ask 42.98 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track TARO in R StocksTrader and adjust your approach as market conditions change in 2025.